Pharmaceutical Technology
March 02, 2011
Issue PDF
35
3
Measuring Spending Levels
March 02, 2011
Insider Solutions
35
3
What to do when your CMO changes the manufacturing equipment line.
March 02, 2011
BioForum
35
3
With a regulatory pathway for follow-on biologics, industry is wondering what FDA will do next.
March 02, 2011
Packaging Forum
35
3
The 2011 show presents ideas for package designs and equipment options for packaging lines.
March 02, 2011
Outsourcing Outlook
35
3
Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
March 02, 2011
Peer Reviewed
35
3
The authors evaluated the manufacturing data of 40-mg tablets of furosemide, a potent diuretic.
March 02, 2011
Online Exclusives
35
3
A revised book on process analytical technology could be valuable to novices and experts.
March 02, 2011
News
35
3
Brazil develops its first national plasma fractionation plant.
March 02, 2011
Peer Reviewed
35
3
The authors investigated the tableting properties of PanExcea MHC300G, a high-performance excipient.
March 02, 2011
Viewpoint
35
3
A single, global tooling standard would offer many benefits, but one has been slow to emerge.
March 02, 2011
Online Exclusives
35
3
The author describes key considerations for drug manufacturers when evaluating packaging partners.
March 02, 2011
Industry Leaders
35
3
Q&A with Robert Hardy, chief executive of Aesica
March 02, 2011
PharmTech Talk
35
3
Social media tools have taken over many aspects of our lives, now including regulatory info.
March 02, 2011
Inside IPEC
35
3
A new audit guide aims to improve supply-chain security and supplier qualification practice.
March 02, 2011
Special Report
35
3
The author provides an overview of QbD implmentation for biopharmaceuticals.
March 02, 2011
Agent-in Place
35
3
Just when things seem to be looking up, the unexpected problem occurs.
March 02, 2011
Special Feature
35
3
The authors review a compliance-by-design approach to quality systems.
March 02, 2011
Special Report
35
3
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2010 and planned for 2011.
March 02, 2011
News
35
3
FDA's efforts to improve access to treatments for rare diseases.
March 02, 2011
Ingredients Insider
35
3
The power of emerging markets is reflected in the pharma's sales and production positions.
March 02, 2011
Peer Reviewed
35
3
The author challenges current detection methodologies.
March 02, 2011
Washington Report
35
3
As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.
March 02, 2011
Special Feature
35
3
This report provides plans for the USP Council's work in the 2010-2015. This articles contains online bonus material.
March 02, 2011
Guest Editorial
35
3
INTERPHEX 2011 aims to address the industry's unique characteristics.